| 000 | 01820 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517224506.0 | ||
| 264 | 0 | _c20181126 | |
| 008 | 201811s 0 0 eng d | ||
| 022 | _a1757-2215 | ||
| 024 | 7 |
_a10.1186/s13048-018-0427-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFurat Rencber, Selenay | |
| 245 | 0 | 0 |
_aEffect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study. _h[electronic resource] |
| 260 |
_bJournal of ovarian research _cJun 2018 |
||
| 300 |
_a55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAMP-Activated Protein Kinases _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 |
_aDehydroepiandrosterone _xadverse effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHormones _xblood |
| 650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
| 650 | 0 | 4 |
_aMetformin _xadministration & dosage |
| 650 | 0 | 4 |
_aOvarian Follicle _xdrug effects |
| 650 | 0 | 4 |
_aOvarian Reserve _xdrug effects |
| 650 | 0 | 4 |
_aOvary _xdrug effects |
| 650 | 0 | 4 |
_aPolycystic Ovary Syndrome _xchemically induced |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aResveratrol |
| 650 | 0 | 4 |
_aSirtuin 1 _xmetabolism |
| 650 | 0 | 4 |
_aStilbenes _xadministration & dosage |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xblood |
| 650 | 0 | 4 |
_aVagina _xpathology |
| 700 | 1 | _aKurnaz Ozbek, Sema | |
| 700 | 1 | _aEraldemır, Ceyla | |
| 700 | 1 | _aSezer, Zehra | |
| 700 | 1 | _aKum, Tugba | |
| 700 | 1 | _aCeylan, Sureyya | |
| 700 | 1 | _aGuzel, Elif | |
| 773 | 0 |
_tJournal of ovarian research _gvol. 11 _gno. 1 _gp. 55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13048-018-0427-7 _zAvailable from publisher's website |
| 999 |
_c28585073 _d28585073 |
||